Jasper Therapeutics (JSPR) Long-Term Investments (2019 - 2021)
Jasper Therapeutics (JSPR) posted quarterly Long-Term Investments of $100.1 million for Q2 2021, little changed year-over-year from $100.4 million in Q2 2020, and little changed quarter-over-quarter from $100.2 million in Q1 2021.
Jasper Therapeutics (JSPR) Long-Term Investments (2019 - 2021) Analysis & Trends
Jasper Therapeutics' Long-Term Investments history runs 3 years deep, the most recent figure standing at $100.1 million for Q2 2021.
- In Q2 2021, Long-Term Investments changed 0.29% year-over-year to $100.1 million; the TTM figure through Jun 2021 stood at $100.1 million (changed 0.29% YoY), while the FY2020 annual figure was $100.3 million, changed 0.18% from the prior year.
- Long-Term Investments for Q2 2021 stood at $100.1 million, roughly flat from $100.2 million in the prior quarter.
- The five-year high for Long-Term Investments was $100.4 million in Q2 2020, with the low at $100.1 million in Q2 2021.
- The 3-year median for Long-Term Investments is $100.3 million (2020), against an average of $100.3 million.
- The sharpest annual moves came in 2020 and 2021: Long-Term Investments rose 0.18% in 2020, then fell 0.29% in 2021.
- Jasper Therapeutics' Long-Term Investments stood at $100.2 million in 2019, then increased by 0.18% to $100.3 million in 2020, then declined by 0.21% to $100.1 million in 2021.
- Business Quant data shows JSPR's Long-Term Investments at $100.1 million in Q2 2021, $100.2 million in Q1 2021, and $100.3 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 5.79 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 9.83 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 1.77 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 22.17 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 372.10 Mn |
| 10 | Jasper Therapeutics | 20.08 Mn | 20.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 100.13 Mn |
| Mar 31, 2021 | 100.20 Mn |
| Dec 31, 2020 | 100.34 Mn |
| Sep 30, 2020 | 100.35 Mn |
| Jun 30, 2020 | 100.42 Mn |
| Mar 31, 2020 | 100.40 Mn |
| Dec 31, 2019 | 100.15 Mn |